Related Experiment Video
Updated: Jun 23, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Taking complement to the clinic--has the time finally come?
1Department of Veterinary Medicine, University of Cambridge, Cambridge, UK. pjl1000@cam.ac.uk
Scandinavian Journal of Immunology
|May 15, 2009
Summary
The complement system, crucial for immunity, is now a promising therapeutic target for inflammatory diseases. New treatments are emerging to harness complement function for treating conditions like age-related macular degeneration.
Area of Science:
- Immunology
- Pharmacology
- Genetics
Background:
- The complement system's role in immunity and inflammation is well-established.
- Translating complement knowledge into effective treatments for immunopathological diseases has been challenging.
- Recent discoveries link complement system mutations to hyperinflammatory states in diseases like age-related macular degeneration.
Purpose of the Study:
- To review the therapeutic potential of targeting the complement system.
- To discuss emerging strategies for developing complement-based therapeutics.
- To explore clinical applications and indications for complement-targeted therapies.
Main Methods:
- Review of existing literature on complement system function.
- Analysis of recent advancements in complement-targeting drug development.
- Discussion of genetic links between complement dysregulation and disease.
Main Results:
- New therapeutic agents designed to modulate complement activity are under development.
- The complement system is increasingly recognized as a key factor in diseases previously considered untreatable.
- Genetic mutations in the complement system can lead to hyperinflammatory conditions.
Conclusions:
- The complement system presents a significant and revitalized therapeutic target.
- Developing complement-based therapies holds promise for treating various inflammatory and immunopathological diseases.
- Clinical translation of complement therapeutics is becoming increasingly feasible, with specific indications emerging.
More Related Videos
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
00:49Complementation Tests
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:27Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
00:59Hospitals-II
Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in hospitals have...
Nurses that work in hospitals have...
01:28Hospitals-I
Hospitals offer medical and surgical care to the sick and injured, along with accommodation while they recover. At the same time, they also provide outpatient, emergency, psychiatric, and rehabilitation services to meet various community needs. In addition to providing medical care, hospitals also act as hubs for medical research and training. Hospitals use clinical procedures and evidence-based practice standards to deliver patient care. To deliver safe and efficient care, a nurse must stay up...